Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse

Transplantation

Volumn 49, Issue 1, 1990, Pages 201-207

  Shoskes, Daniel A ^a   Parfrey, Nollaig A ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; HISTOCHEMISTRY; HISTOLOGY; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; ISCHEMIA; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MICE; MICE, INBRED CBA; SUPPORT, NON-U.S. GOV'T;

EID: 0025176643     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199001000-00045     Document Type: Article

References (35)

1. Whittaker JR, Veith FJ, Soberman R, et al. The fate of the renal transplant with delayed function. Surg Gynecol Obstet 1973; 136: 919.
2. Opelz G, Sasaki N, Terasaki PI. Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation 1978; 25: 212.
3. Besarab A, Jarrell B, Ihle BU, Colberg JE, Burke JF, Wesson L. Adverse effects of prophylactic irradiation and acute tubular necrosis on renal graft function and survival. Nephron 1982; 31: 347.
4. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984; 38: 643.
5. Canafax DM, Torres A, Fryd DS, et al. The effects of delayed function on recipients of cadaver renal allografts: a study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 1986; 41: 177.
6. Halloren PF, Aprile MA, Farewell V, et al. Early function as the January 1990 SHOSKES ET AL. 207
7. Cho SI, Olsson CA, Bradley JW, Nasbeth DC. Regional program for kidney preservation and transplantation in New England. Am J Surg 1976; 131: 428.
8. Mendez-Picon G, Posner MP, McGeorge MB, et al. The effect of delayed function on long term survival of renal allografts. Surg Gynecol Obstet 1985; 161: 351.
9. Barry JM, Shively N, Hubert B, Hefty T, Norman DJ, Bennett WM. Significance of delayed graft function in cyclosporinetreated recipients of cadaver kidney transplants. 1988; 45: 346.
10. Klein J, Juretic A, Baxevanis CN, Nagy ZA. The traditional and a new version of the mouse H-2 complex. Nature 1981; 291: 455.
11. Bekkhoucha F, Naquet P, Pierres A, Marchetto S, Pierres M. Efficiency of antigen presentation to T cell clones by (B cell X B cell lymphoma) hybridomas correlates quantitatively with cell surface la antigen expression. Eur J Immunol 1984; 14: 807.
12. King NJC, Mullbacher A, Blanden RV. Relationship between surface H-2 concentration, size of different target cells, and lysis by cytotoxic T cells. Cell Immunol 1986; 98: 525.
13. Bishop GA, Waugh JA, Hall BM. Expression of HLA antigens on renal tubular cells in culture: II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation 1988; 46: 303.
14. Milton AD, Spencer SC, Fabre JW. Detailed analysis and demonstration of differences in the kinetics of induction of class I and class II major histocompatibility complex antigens in rejecting cardiac and kidney allografts in the rat. Transplantation 1986; 41: 499.
15. Forbes RDC, Parfrey NA, Gomersall M, Darden AG, Guttmann RD. Dendritic cell-lymphoid cell aggregation and major histocompatibility complex antigen expression during rat cardiac allograft rejection. J Exp Med 1986; 164: 1239.
16. Benson EM, Colvin RB, Russell PS. Induction of IA antigens in murine renal transplants. J Immunol 1985; 134: 7.
17. Häyry P, von Willebrand E, Ahonen J, Eklund B. Do well-to-do and repeatedly rejecting renal allografts express the transplantation antigens similarly on their surface? Scand J Urol Nephrol 1981; Suppl 64: 52.
18. Hall BM, Duggin GG, Philips J, et al. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 1984; 2: 247.
19. Fuggle SV, McWhinnie DL, Chapman J, Taylor HM, Morris PJ. Sequential analysis of HLA-class II antigen expression in human renal allografts. Transplantation 1986; 42: 144.
20. Wood KJ, Hopley A, Dallman MJ, Morris PJ. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Transplantation 1988; 45: 759.
21. Oi VT, Jones PP, Goding JW, Herzenberg LA. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and la antigens. Curr Top Microbiol Immunol 1978; 81:115.
22. Ledbetter JA, Herzenberg LA. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63.
23. Cockfield SM, Ramasser V, Urmson J, Halloran PF. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 1989; 142: 1120.
24. Halloran PF, Urmson J, Ramasser V, Laskin C, Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988; 141: 2303.
25. Parnes JR, Velan B, Felsenfeld A, et al. Mouse j32-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNA’s. Proc Natl Acad Sei USA 1981; 78: 2253.
26. Davis MM, Cohen DI, Nielsen E, Steinmetz M, Paul WE, Hood L. Cell-type-specific cDNA probes and the murine I region: the localization and orientation of A-a. Proc Natl Acad Sei USA 1984; 81: 2194.
27. Shen-Ong GLC, Keath EJ, Piccoli ST, Cole MD. Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 1982; 31: 443.
28. Cleveland DW, Lopata MA, MacDonald RJ, et al. Number and evolutionary conservation of a- and ß- tubulin and cytoplasmic ß- and 7 - actin genes using specific cloned cDNA probes. Cell 1980; 20: 95.
29. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF. Regulation of MHC expression in vivo: bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cellindependent, cyclosporine sensitive mechanism. J Immunol 1988; 141: 792.
30. Halloran PF, Urmson J, Farkas S, et al. Effects of cyclosporine on systemic MHC expression: evidence that non-T cells produce interferon-gamma in vivo and are inhibitable by cyclosporine. Transplantation 1988; 46: 68S.
31. Halloran PF, Jephthah-Ochola J, Urmson J, Farkas S. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney. J Immunol 1985; 135: 1053.
32. Halloran PF, Urmson J, van der Meide PH, Autenried P. Regulation of MHC expression in vivo: II. Interferon a/ß inducers and recombinant interferon a modulate MHC Ag expression in mouse tissues. J Immunol 1989; 142: 4241.
33. Lapierre LA, Fiers W, Pober JS. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. J Exp Med 1988; 167: 794.
34. Halloran PF, Wadgymar A, Autenried P. The regulation o f expression of major histocompatibility complex products. Transplantation 1986; 41: 413.
35. Solez KS, McGraw DJ, Beschorner WE, Burdick JF. Pathology of “acute tubular necrosis” and acute rejection: observations on early systemic renal transplant biopsies. In: Williams GM, Burdick JF, Solez KS, eds. Kidney transplant rejection. New York: Marcel Dekker, 1986: 207.